We are live on ! Find out more
Norwest Venture Partners XIV

Norwest Venture Partners XIV Portfolio holdings

AUM $60.4M Turnover 0%
1-Year Est. Return 9.56%
This Fund
S&P 500
This Quarter Est. Return
+29.34%
1 Year Est. Return
+9.56%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$60.4M
AUM Growth
-$26.2M
Cap. Flow
-$37.3M
Cap. Flow %
-61.77%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
1
Closed
–
Avg Time Held
0.5 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.5 years

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
OPEN icon
Opendoor
OPEN
+$37.3M

Sector Composition

Rank Sector Weight
1 Healthcare 62.06%
2 Real Estate 37.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
IMPL
1
DELISTED
Impel Pharmaceuticals
IMPL
$37.5M 62.06%
3,077,198
– –
2021 Q2
1 quarter
OPEN icon
2
Opendoor
OPEN
$1.1B
$22.9M 37.94%
1,153,391
-2,306,783
-67% -$37.3M
2020 Q4
3 quarters

Similar funds

Norwest Venture Partners XIV's Q3 2021 Portfolio in Review

As of Q3 2021, Norwest Venture Partners XIV held 2 positions worth $60.4M, down 30% from $86.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Norwest Venture Partners XIV withdrew a net $37.3M in Q3 2021, reducing 1 holding. Its largest reduction was Opendoor, cutting an estimated $37.3M.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 31% a quarter earlier, followed by Real Estate.

  • Norwest Venture Partners XIV's biggest Q3 2021 reduction was Opendoor, cutting an estimated $37.3M.
  • Norwest Venture Partners XIV's ten largest holdings make up 100% of its $60.4M portfolio in Q3 2021.
  • Norwest Venture Partners XIV opened 0 new positions and closed 0 in Q3 2021.
  • Norwest Venture Partners XIV's portfolio value fell 30% quarter-over-quarter to $60.4M.

Based on Norwest Venture Partners XIV's 13F filing for Q3 2021, filed 27 Oct 2021.